Publications by authors named "Joshua W D Tobin"

Claim this Profile
A
An Economic Evaluation of the TROG 99.03 Trial: Systemic Therapy After Radiotherapy in Early-Stage Follicular Lymphoma.
Daniel Erku, Joshua W D Tobin, John F Seymour, Michael MacManus, Paul Scuffham

EJHaem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma.
Michael P MacManus, John F Seymour, Hennes Tsang, Richard Fisher, Colm Keane, Joshua W D Tobin

EBioMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for high-risk defining events in follicular lymphoma following frontline immunochemotherapy.
Joshua W D Tobin, Venkata A Chikatamarla, Marko Matic, Alison Griffin, Rakin Chowdhury

Blood Neoplasia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.
Jay Gunawardana, Soi C Law, Muhammed B Sabdia, Éanna Fennell, Aoife Hennessy, Joshua W D Tobin

Am J Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
Joshua W D Tobin, Greg Hapgood, Anna Johnston, Chan Y Cheah, Sze T Lee

Intern Med J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epstein-Barr virus-associated lymphomas decoded.
Karolina Bednarska, Rakin Chowdhury, Joshua W D Tobin, Fiona Swain, Colm Keane

Br J Haematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PO4-tential for Less Toxic CAR T-cell Therapies.
Joshua W D Tobin, Michael R Green, Maher K Gandhi

Cancer Immunol Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance.
Greg Hapgood, Maya Latimer, Sze Ting Lee, Bryone Kuss, Stephen Lade, Joshua W D Tobin

Intern Med J· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-effectiveness analysis of front-line treatment strategies in early-stage follicular lymphoma.
Joshua W D Tobin, Anna Crothers, Ti Eric Ma, Peter Mollee, Maher K Gandhi

Leuk Lymphoma· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance.
Stephen Boyle, Joshua W D Tobin, Jacinta Perram, Nada Hamad, Veena Gullapalli

Hemasphere· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of Epstein-Barr virus-associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third-party Epstein-Barr virus-specific T cells.
Soi C Law, Thanh Hoang, Kacey O'Rourke, Joshua W D Tobin, Jay Gunawardana

Am J Transplant· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma.
Karthik Nath, Soi-Cheng Law, Muhammed B Sabdia, Jay Gunawardana, Lilia M de Long, Joshua W D Tobin

Blood Adv· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordant solutions to discordant problems.
Joshua W D Tobin, Maher K Gandhi

Blood· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma.
Joshua W D Tobin, Karolina Bednarska, Ashlea Campbell, Colm Keane

Cells· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted therapy in follicular lymphoma: Is it time to "FLEX"?
Joshua W D Tobin, Maher K Gandhi

Am J Hematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic aberrations of are associated with downregulated MHC-I antigen presentation and impaired T-cell immunity in follicular lymphoma.
Jay Gunawardana, Justina N Lee, Karolina Bednarska, Valentine Murigneux, Lilia Merida de Long, Joshua W D Tobin

EJHaem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma.
Deepak Bararia, Johannes A Hildebrand, Sebastian Stolz, Sarah Haebe, Stefan Alig, Joshua W D Tobin

Cell Rep· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to M. Sorigue.
Joshua W D Tobin, Colm Keane, Jay Gunawardana, Maher K Gandhi

J Clin Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration.
Joshua W D Tobin, Colm Keane, Jay Gunawardana, Peter Mollee, Simone Birch

J Clin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance.
Joshua W D Tobin, Gabrielle Rule, Katherine Colvin, Lourdes Calvente, David Hodgson

Blood Adv· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis